GlassScriptPhysician profile
Holly L Christman
NPI 1275567323
$1,304.87
in general payments reported to CMS, 2019-2025
14 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $685 · 2020: $43.35 · 2021: $60.92 · 2022: $45.68 · 2023: $212 · 2024: $128 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $466.35 | 2019-2025 | Botox |
| Novartis Pharmaceuticals Corporation | $243.81 | 2019-2022 | |
| Galderma Laboratories, L.P. | $138.47 | 2019 | |
| Leo Pharma INC. | $129.46 | 2019-2025 | Adbry |
| Allergan, INC. | $58.84 | 2020-2022 | |
| Lilly USA, LLC | $54.37 | 2024 | Olumiant, Taltz |
| Incyte Corporation | $47.05 | 2023 | Opzelura |
| Regeneron Pharmaceuticals, INC. | $45.00 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $24.72 | 2019 | |
| Dusa Pharmaceuticals, INC. | $21.82 | 2019 | |
| Amgen INC. | $20.15 | 2023 | Otezla |
| Sun Pharmaceutical Industries INC. | $20.12 | 2019 | |
| Janssen Biotech, INC. | $18.74 | 2019 | |
| Mission Pharmacal Company | $15.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Christman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.